ASCO GU 2023 Conference Coverage

 

ASCO GU 2023 Conference Coverage
A

ASCO GU 2023 Efficacy of Systemic Therapy Following [177Lu]Lu-PSMA in Patients With mCRPC

By ASCO GU 2023 Conference Coverage FEATURING Arun Azad
By ASCO GU 2023 Conference Coverage FEATURING Arun Azad
135 views
March 2, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
07:52

Independent Biomarkers Predictive of Outcomes With Enfortumab Vedoti…

ASCO GU 2023 Conference Coverage

T. Jindal

98 views
06:49

ASCO GU 2023 DEAR Study: Real-World Use of Darolutamide, Enzalutamid…

ASCO GU 2023 Conference Coverage

D. George

374 views
12:39

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

ASCO GU 2023 Conference Coverage

C. Sternberg

1.4K views
08:18

ASCO GU 2023 Real-World Effectiveness of Darolutamide in mCRPC

ASCO GU 2023 Conference Coverage

A. Liang

123 views
05:39

ASCO GU 2023 Analysis of the UNITE Study: Biomarkers of Response to …

ASCO GU 2023 Conference Coverage

T. Jindal

103 views
11:07

ASCO GU 2023 Innovative and Pragmatic Methods to Study BCG-Unrespons…

ASCO GU 2023 Conference Coverage

J. Gore

51 views
07:09

ASCO GU 2023 HER2 Expression in Urothelial Carcinoma

ASCO GU 2023 Conference Coverage

V. Koshkin

87 views
07:23

ASCO GU 2023 Response & Outcomes of Maintenance Avelumab After Plati…

ASCO GU 2023 Conference Coverage

P. Grivas, D. Bakaloudi

253 views
10:44

ASCO GU 2023 Additional Results From the Randomized Phase 2 CheckMat…

ASCO GU 2023 Conference Coverage

R. Pachynski

305 views
07:06

ASCO GU 2023 JAVELIN Bladder 100 Trial: Avelumab 1L Maintenance for …

ASCO GU 2023 Conference Coverage

K. Sridhar

265 views
05:40

ASCO GU 2023 International Phase 3 Randomised Controlled PACE-A Tria…

ASCO GU 2023 Conference Coverage

N. van As

101 views
08:32

ASCO GU 2023 Real-World Assessment of AR-LBD Mutations in mCRPC

ASCO GU 2023 Conference Coverage

E. Antonarakis

66 views
07:36

ASCO GU 2023 Assessment of Clavien-Dindo Classification in Patients …

ASCO GU 2023 Conference Coverage

K. Runcie

88 views
05:31

ASCO GU 2023 Phase I/II AlphaBet Trial: Evaluating the Combination o…

ASCO GU 2023 Conference Coverage

A. Azad

59 views
04:34

ASCO GU 2023 Phase I/II LuCAB Trial: Evaluating Cabazitaxel in Combi…

ASCO GU 2023 Conference Coverage

A. Azad

141 views
05:20

ASCO GU 2023 Efficacy of Systemic Therapy Following [177Lu]Lu-PSMA i…

ASCO GU 2023 Conference Coverage

A. Azad

135 views
03:05

ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…

ASCO GU 2023 Conference Coverage

M. Zibelman

265 views
05:47

ASCO GU 2023 Outcomes by IMDC Risk in the COSMIC-313 Phase 3 Trial: …

ASCO GU 2023 Conference Coverage

T. Powles

212 views
07:03

ASCO GU 2023 Real-World Evidence From Four High-Volume Institutions:…

ASCO GU 2023 Conference Coverage

O. Caffo

42 views
10:24

ASCO GU 2023 Real-World Data from an Italian Multicenter Observation…

ASCO GU 2023 Conference Coverage

O. Caffo

47 views
07:49

ASCO GU 2023 First Analysis From an Italian Multicenter Observationa…

ASCO GU 2023 Conference Coverage

O. Caffo

109 views
12:48

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A …

ASCO GU 2023 Conference Coverage

M. Kohli

243 views
07:53

ASCO GU 2023 Phase 3 IMvigor130 Study: Final OS Analysis of Atezo Mo…

ASCO GU 2023 Conference Coverage

A. Bamias

93 views
13:01

ASCO GU 2023 Interim Analysis of the Prospective Phase II COTRIMS Tr…

ASCO GU 2023 Conference Coverage

A. Heidenreich

96 views
09:47

FDA Announcement Based on the MAGNITUDE Trial: Niraparib With Abirat…

ASCO GU 2023 Conference Coverage

E. Efstathiou

197 views
01:46

ASCO GU 2023 Randomized Double-Blind Phase 3 KEYNOTE-921 Study: Pemb…

ASCO GU 2023 Conference Coverage

D. Petrylak

281 views
08:45

ASCO GU 2023 Machine-Learning to Predict Utility of ctDNA for Somati…

ASCO GU 2023 Conference Coverage

C. Herberts

29 views
04:49

ASCO GU 2023 Updated Outcomes in TROPHY-U-01 Cohort 1-A Phase 2 Stud…

ASCO GU 2023 Conference Coverage

S. Tagawa

167 views
05:48

ASCO GU 2023 Randomized Double-Blinded Phase II Study of Keto HC and…

ASCO GU 2023 Conference Coverage

S. Tagawa

42 views
14:09

ASCO GU 2023 Exposure Toxicity and Response Relationship of Cabozant…

ASCO GU 2023 Conference Coverage

Y. Vano

93 views
04:20

ASCO GU 2023 CaboPoint Phase 2 Study: Cabozantinib After Checkpoint …

ASCO GU 2023 Conference Coverage

L. Albiges

128 views
05:32

ASCO GU 2023 Cell-Free utDNA to Detect MRD Prior to Repeat-Transuret…

ASCO GU 2023 Conference Coverage

K. Rose

77 views
14:01

ASCO GU 2023 Active Surveillance for Favorable Intermediate-Risk Pro…

ASCO GU 2023 Conference Coverage

A. D'Amico

154 views
12:05

ASCO GU 2023 Novel Guidelines for PSMA PET Staging of Prostate Cance…

ASCO GU 2023 Conference Coverage

D. Nanus

329 views
12:01

ASCO GU 2023 Sequential Enfortumab Vedotin After Platinum-Based Chem…

ASCO GU 2023 Conference Coverage

P. Cen

252 views
08:15

ASCO GU 2023 3-Year Follow-Up From The Phase 3 CheckMate 9ER Trial: …

ASCO GU 2023 Conference Coverage

M. Burotto

371 views
15:17

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

ASCO GU 2023 Conference Coverage

T. Zhang

829 views
02:42

ASCO GU 2023 Day Three Highlights With Resident Jindal and Dr. Park

ASCO GU 2023 Conference Coverage

T. Jindal, C. Park

37 views
22:25

ASCO GU 2023 Prostate and Bladder Updates With Dr. Jones and Dr. Park

ASCO GU 2023 Conference Coverage

R. Jones, C. Park

132 views
09:22

ASCO GU 2023: Dr. Park and Dr. Grivas Discuss TROPHY-U-01 and EV-201…

ASCO GU 2023 Conference Coverage

P. Grivas, C. Park

661 views
08:13

ASCO GU 2023 Dr. Plimack and Dr. Park Discuss Over-Treating in Muscl…

ASCO GU 2023 Conference Coverage

E. Plimack, C. Park

627 views
08:59

ASCO GU 2023 Treatment Outcomes With New Targeted Agents in Advanced…

ASCO GU 2023 Conference Coverage

V. Koshkin, C. Park

221 views
06:04

ASCO GU 2023 Phase II Study Rucaparib Monotherapy in Pts With nmHSPC…

ASCO GU 2023 Conference Coverage

K. Sahu, C. Park

113 views
06:34

ASCO GU 2023 Dr. Flaig and Dr. Park Discuss Updates in Prostate and …

ASCO GU 2023 Conference Coverage

T. Flaig, C. Park

446 views
05:18

ASCO GU 2023: Dr. Miron and Dr. Park Discuss Kidney and Bladder Upda…

ASCO GU 2023 Conference Coverage

B. Miron, C. Park

510 views
06:19

ASCO GU 2023: Dr. Park and Dr. Gupta Discuss the BLASST-1 Study

ASCO GU 2023 Conference Coverage

S. Gupta, C. Park

229 views
09:12

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients With Advanc…

ASCO GU 2023 Conference Coverage

A. Basu, C. Park

249 views
03:08

ASCO GU 2023 Day Two Highlights With Dr. Talukder and Dr. Park

ASCO GU 2023 Conference Coverage

R. Talukder, C. Park

35 views
10:32

ASCO GU 2023 Dr. Rettig and Dr. Park Discuss Prostate Cancer Updates

ASCO GU 2023 Conference Coverage

M. Rettig, C. Park

223 views
05:57

ASCO GU 2023 Comparison of ctDNA Between African-American and Caucas…

ASCO GU 2023 Conference Coverage

A. Jang, C. Park

242 views
10:01

ASCO GU 2023 Bladder Cancer Highlights With Dr. Sonpavde and Dr. Park

ASCO GU 2023 Conference Coverage

G. Sonpavde, C. Park

620 views
01:53

ASCO GU 2023 Day One Highlights With Dr. Zakharia

ASCO GU 2023 Conference Coverage

Y. Zakharia

83 views